Voclosporin denied for missing prior authorization by Aetna?

Aetna's specific coverage criteria for voclosporin are defined in its own published medical/coverage policy and the FDA-approved prescribing label. A successful appeal documents that your medical records satisfy each criterion those sources list — confirmed diagnosis, any required prior treatments (with dates and outcomes), and clinical severity. If the exact criteria weren't included with your denial, request them in writing; your appeal then maps each requirement to the matching fact in your chart.

## Why Aetna Requires Prior Authorization for Voclosporin

As a specialty drug for a serious autoimmune condition, voclosporin sits behind Aetna's prior authorization (PA) gate. A "prior authorization required" denial typically means the prescription was sent to the pharmacy without a PA on file, or the PA submission was incomplete or did not clearly satisfy Aetna's clinical criteria. This is an administrative hurdle, not a clinical rejection — the path forward is straightforward.

## Step One: Submit or Resubmit the PA

If no PA was submitted, your prescriber's office should initiate one immediately through Aetna's provider portal or by fax. Ensure the submission includes: - The correct diagnosis code matching the FDA-approved indication for voclosporin - Clinical documentation of active lupus nephritis (biopsy, lab trends, physician notes) - Documentation of any required prior treatments per Aetna's policy - The prescriber's signed attestation of medical necessity

Ask Aetna's PA team for the specific clinical criteria checklist — they are required to provide it.

## If the PA Is Denied After Submission

A PA denial triggers full appeal rights:

• Internal appeal (ERISA §503): File within the deadline on the denial notice. Include any documentation that was missing from the original PA submission.
• External review (ACA §2719): If the internal appeal fails, request binding external review within approximately four months of the final internal denial.
• Expedited PA and appeal: If the patient's condition is urgent, request an expedited PA review (typically 72 hours) and, if denied, simultaneous expedited internal and external appeal.

## Documentation to Gather

1. Diagnosis confirmation — biopsy report, treating specialist's notes, current clinical status documenting active lupus nephritis. 2. Step-therapy compliance — if Aetna's criteria require prior use of other agents, provide dated records of those treatments and outcomes. 3. Background therapy documentation — evidence that the required concomitant immunosuppressive regimen is prescribed and being taken, per the FDA label. 4. Prescriber medical-necessity letter — a letter specifically addressing each criterion in Aetna's PA policy, supported by chart references rather than general assertions. 5. Aetna's clinical criteria document — obtain and attach this so the appeal reviewer can see you have addressed every listed requirement.

## Criteria-Mapping Structure

Obtain Aetna's prior authorization criteria for voclosporin (available through the provider portal or by request). Create a table:

| Aetna PA Criterion | Chart Documentation Provided | |---|---| | Confirmed active lupus nephritis | Biopsy date and class; specialist note | | Required background therapy in use | Prescription + pharmacy records | | Prior treatment history (if required) | Dated treatment log | | Prescriber specialty (if required) | Nephrologist/rheumatologist credential |

A well-organized, criterion-by-criterion PA submission is approved the majority of the time. Appeals succeed when the resubmission fills the gap that caused the original denial.